Acrivon Therapeutics, Inc.
ACRV
$8.46
-$0.01-0.12%
Headlines
4/27/2024
-
TipRanks Financial Blog
4/27/2024
-
Zolmax
4/27/2024
-
Ticker Report
4/26/2024
-
The Fly
4/26/2024
-
Ticker Report
4/25/2024
-
The Fly
4/25/2024
-
The Fly
4/25/2024
-
The Fly
4/25/2024
-
The Fly
4/25/2024
-
The Fly
4/24/2024
-
The Fly
4/24/2024
-
Globe Newswire
4/24/2024
-
The Fly
4/22/2024
-
TipRanks Financial Blog
4/21/2024
-
24/7 Wall St.
4/18/2024
-
Zolmax
4/17/2024
-
The Fly
4/17/2024
-
Globe Newswire
4/16/2024
-
Zolmax
4/10/2024
-
TipRanks Financial Blog
4/10/2024
-
The Fly
4/9/2024
-
Benzinga
4/9/2024
-
InvestorPlace
4/9/2024
-
Benzinga
Filings
Thursday, March 28, 2024
Sunday, December 31, 2023
Week of May 6 and 10 (est)
Price History
--
--
--
--
Business Description
Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific...
more